Sage Journals: Discover world-class research

Open access

Research article

First published 2024

Cost-effectiveness of acalabrutinib monotherapy or with obinutuzumab versus chemoimmunotherapy for untreated chronic lymphocytic leukemia in China

Mengya Li, Xiaoyan Zhong, Chengbin Zhang [...]

Therapeutic Advances in Hematology

Free access

Research article

First published 2018-6

Pancreatic Effects of a Bruton’s Tyrosine Kinase Small-molecule Inhibitor in Rats Are Strain-dependent

Manoj Bhaskaran, Paul D. Cornwell, Steven D. Sorden [...]

Toxicologic Pathology

Open access

Case report

First published 2024

Successful treatment of hemophagocytic intravascular large B-cell lymphoma with CNS involvement with BTK inhibitor combined with rituximab and high-dose methotrexate

Fangfei Shao, Wei Su, Xiujie Zhao [...]

Therapeutic Advances in Hematology

Retricted access

Case report

First published 2024-12

CNS Aspergillosis and Cryptococcosis with Cytomegalovirus Pneumonia in a Patient with Chronic Lymphocytic Leukemia Treated with Acalabrutinib

Taylor Fallin, Erica Thacker, Syeda Sahra [...]

Journal of Pharmacy Practice

Free access

Review article

First published 2024-1

Pirtobrutinib: A novel non-covalent BTK inhibitor for the treatment of adults with relapsed/refractory mantle cell lymphoma

Dominique D Davis, Zahava Ohana, Huy M Pham

Journal of Oncology Pharmacy Practice

Retricted access

Case report

First published 2023

Hypophosphatemia related to the use of ibrutinib

Mine Karadeniz, Olgu Erkin Cinar, Batuhan Erdogdu [...]

Journal of Oncology Pharmacy Practice

Open access

Brief report

First published 2025

Efficacy of zanubrutinib versus acalabrutinib for relapsed or refractory chronic lymphocytic leukemia (R/R CLL): a matching-adjusted indirect comparison (MAIC)

Mazyar Shadman, Jennifer R. Brown, Rhys Williams [...]

Therapeutic Advances in Medical Oncology

Open access

Research article

First published 2019-12

Bruton’s Tyrosine Kinase Inhibition Promotes Myelin Repair

Elodie Martin, Marie-Stéphane Aigrot, Roland Grenningloh [...]

Brain Plasticity

Open access

Review article

First published 2022

Updates in hairy cell leukemia (HCL) and variant-type HCL (HCL-V): rationale for targeted treatments with a focus on ibrutinib

Jérôme Paillassa, Firas Safa, Xavier Troussard

Therapeutic Advances in Hematology

Open access

Research article

First published 2025

Do all roads lead to Rome? The heterogeneity of relapsed/refractory diffuse large B-cell lymphoma patients who achieved therapies response and received autologous stem cell transplantation in the era of new targeted drugs

Jiangtao Li, Wenxuan Huo, Yang Yang [...]

Cell Transplantation

Search results